90 related articles for article (PubMed ID: 2268906)
1. Inhibitory effect of fumaric acid on hepatocarcinogenesis by thioacetamide in mice.
Akao M; Kuroda K
Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2012-4. PubMed ID: 2268906
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of fumaric acid on hepatocarcinogenesis by thioacetamide in rats.
Kuroda K; Terao K; Akao M
J Natl Cancer Inst; 1987 Nov; 79(5):1047-51. PubMed ID: 3479633
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of fumaric acid on 3'-methyl-4-(dimethylamino)azobenzene-induced hepatocarcinogenesis in rats.
Kuroda K; Akao M
Chem Pharm Bull (Tokyo); 1989 May; 37(5):1345-6. PubMed ID: 2517046
[TBL] [Abstract][Full Text] [Related]
5. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of fumaric acid on forestomach and lung carcinogenesis by a 5-nitrofuran naphthyridine derivative in mice.
Kuroda K; Kanisawa M; Akao M
J Natl Cancer Inst; 1982 Dec; 69(6):1317-20. PubMed ID: 6958908
[TBL] [Abstract][Full Text] [Related]
7. Thioacetamide hepatocarcinogenesis.
Becker FF
J Natl Cancer Inst; 1983 Sep; 71(3):553-8. PubMed ID: 6577229
[TBL] [Abstract][Full Text] [Related]
8. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
[TBL] [Abstract][Full Text] [Related]
9. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
Abe M; Yoshida T; Akiba J; Ikezono Y; Wada F; Masuda A; Sakaue T; Tanaka T; Iwamoto H; Nakamura T; Sata M; Koga H; Yoshimura A; Torimura T
World J Gastroenterol; 2017 Oct; 23(37):6833-6844. PubMed ID: 29085226
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of fumaric acid on 3-methyl-4'-(dimethylamino)-azobenzene-induced hepatocarcinogenesis in rats.
Kuroda K; Terao K; Akao M
J Natl Cancer Inst; 1983 Oct; 71(4):855-7. PubMed ID: 6413745
[TBL] [Abstract][Full Text] [Related]
11. Effect of partial hepatectomy on tumor incidence and metabolism of mice fed thioacetamide.
Date PA; Gothoskar SV; Bhide SV
J Natl Cancer Inst; 1976 Mar; 56(3):493-7. PubMed ID: 176394
[TBL] [Abstract][Full Text] [Related]
12. Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
Abe H; Ogawa T; Wang L; Kimura M; Tanaka T; Morita R; Yoshida T; Shibutani M
Toxicol Appl Pharmacol; 2014 Nov; 280(3):467-74. PubMed ID: 25151969
[TBL] [Abstract][Full Text] [Related]
13. Identification of epigenetically downregulated Tmem70 and Ube2e2 in rat liver after 28-day treatment with hepatocarcinogenic thioacetamide showing gene product downregulation in hepatocellular preneoplastic and neoplastic lesions produced by tumor promotion.
Mizukami S; Yafune A; Watanabe Y; Nakajima K; Jin M; Yoshida T; Shibutani M
Toxicol Lett; 2017 Jan; 266():13-22. PubMed ID: 27914986
[TBL] [Abstract][Full Text] [Related]
14. An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features.
Romualdo GR; Grassi TF; Goto RL; Tablas MB; Bidinotto LT; Fernandes AAH; Cogliati B; Barbisan LF
Toxicol Lett; 2017 Nov; 281():84-94. PubMed ID: 28943392
[TBL] [Abstract][Full Text] [Related]
15. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats.
Noda S; Masumi S; Moriyama M; Kannan Y; Ohta M; Sugano T; Yamate J
Hepatology; 1996 Aug; 24(2):412-8. PubMed ID: 8690413
[TBL] [Abstract][Full Text] [Related]
16. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.
Zhou Z; Park S; Kim JW; Zhao J; Lee MY; Choi KC; Lim CW; Kim B
Toxicol Mech Methods; 2017 Sep; 27(7):501-510. PubMed ID: 28440100
[TBL] [Abstract][Full Text] [Related]
17. Depletion of Hepatic Macrophages Aggravates Liver Lesions Induced in Rats by Thioacetamide (TAA).
Golbar HM; Izawa T; Wijesundera KK; Bondoc A; Tennakoon AH; Kuwamura M; Yamate J
Toxicol Pathol; 2016 Feb; 44(2):246-58. PubMed ID: 26957569
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats.
Tanaka T; Kojima T; Kawamori T; Yoshimi N; Mori H
Cancer Res; 1993 Jun; 53(12):2775-9. PubMed ID: 8504418
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis.
Chen IS; Chen YC; Chou CH; Chuang RF; Sheen LY; Chiu CH
J Sci Food Agric; 2012 May; 92(7):1441-7. PubMed ID: 22102319
[TBL] [Abstract][Full Text] [Related]
20. Mice deficient in aldo-keto reductase 1a (Akr1a) are resistant to thioacetamide-induced liver injury.
Homma T; Shirato T; Akihara R; Kobayashi S; Lee J; Yamada KI; Miyata S; Takahashi M; Fujii J
Toxicol Lett; 2018 Sep; 294():37-43. PubMed ID: 29763686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
